Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-02

Clinical Trial Update: Major Depressive Disorder In The Elderly [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on major depressive disorder in the elderly; the study sponsored by GlaxoSmithKline is noted as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED